{"log_id": 771875775602302225, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 1.1e-05, "average": 0.998394, "min": 0.98408}, "location": {"width": 786, "top": 217, "height": 37, "left": 259}, "words": "在毒理学研究中,以大于或等于6倍的人体暴露水平(以AUC计)对大鼠、犬"}, {"probability": {"variance": 1e-05, "average": 0.998292, "min": 0.982709}, "location": {"width": 819, "top": 262, "height": 35, "left": 217}, "words": "猴给予替诺福韦和富马酸替诺福韦二吡呋酯,出现了骨毒性。在猴中,骨毒性被诊断"}, {"probability": {"variance": 2e-05, "average": 0.997833, "min": 0.97673}, "location": {"width": 824, "top": 306, "height": 34, "left": 218}, "words": "为骨软化症。在猴中,替诺福韦减量或停用后,骨软化症呈现出可逆性。在大鼠和犬"}, {"probability": {"variance": 0.000255, "average": 0.980389, "min": 0.956552}, "location": {"width": 27, "top": 218, "height": 129, "left": 1143}, "words": "一食附一"}, {"probability": {"variance": 7e-06, "average": 0.998256, "min": 0.9902}, "location": {"width": 598, "top": 350, "height": 32, "left": 215}, "words": "中,骨毒性表现为骨矿物质密度降低。骨毒性的潜在机制未知"}, {"probability": {"variance": 1.2e-05, "average": 0.998148, "min": 0.981806}, "location": {"width": 774, "top": 393, "height": 36, "left": 259}, "words": "在4种动物中发现了肾毒性的证据。在这些动物中,观察到了不同程度的血清肌"}, {"probability": {"variance": 9.3e-05, "average": 0.997067, "min": 0.942037}, "location": {"width": 805, "top": 436, "height": 35, "left": 213}, "words": "酐、尿酸氮、糖尿、蛋白尿、磷酸尿、和或钙尿增加以及血磷降低。这些毒性是在"}, {"probability": {"variance": 0.002303, "average": 0.989002, "min": 0.698887}, "location": {"width": 805, "top": 480, "height": 32, "left": 214}, "words": "比人高2-20倍的暴露水平(以AUC计)下观察到的。肾脏异常尤其是磷酸尿与骨"}, {"probability": {"variance": 1e-06, "average": 0.998956, "min": 0.996389}, "location": {"width": 156, "top": 524, "height": 28, "left": 214}, "words": "毒性的关系未知"}, {"probability": {"variance": 6.8e-05, "average": 0.995725, "min": 0.977354}, "location": {"width": 116, "top": 601, "height": 26, "left": 219}, "words": "药代动力学]"}, {"probability": {"variance": 0.003789, "average": 0.984441, "min": 0.649608}, "location": {"width": 818, "top": 651, "height": 37, "left": 211}, "words": "在健康志愿者和HIV-1感染者中评估了富马酸替诺福韦二吡呋酯的药代动力学。这些"}, {"probability": {"variance": 7e-06, "average": 0.998608, "min": 0.989564}, "location": {"width": 332, "top": 681, "height": 29, "left": 212}, "words": "人群中替诺福韦的药代动力学相似"}, {"probability": {"variance": 9e-06, "average": 0.998648, "min": 0.98203}, "location": {"width": 814, "top": 728, "height": 41, "left": 210}, "words": "吸收:富马酸替诺福韦二吡呋酯是活性成分替诺福韦的水溶性双酯前体药物。在空腹"}, {"probability": {"variance": 3e-05, "average": 0.997024, "min": 0.969253}, "location": {"width": 796, "top": 757, "height": 41, "left": 210}, "words": "服用富马酸替诺福韦二吡呋酯的受试者中,替诺福韦的口服生物利用度大约为25%"}, {"probability": {"variance": 0.007139, "average": 0.975206, "min": 0.589652}, "location": {"width": 823, "top": 787, "height": 41, "left": 212}, "words": "在空腹状态下,HIV-1感染受试者单次口服富马酸替诺福韦二吡呋酯300mg,在1.0±"}, {"probability": {"variance": 0.003803, "average": 0.975488, "min": 0.675753}, "location": {"width": 815, "top": 817, "height": 40, "left": 210}, "words": "04小时内达到最高血清浓度(Cma)。Cmax和AUC值分别是296±90ng/mL和2287"}, {"probability": {"variance": 0.00014, "average": 0.99248, "min": 0.956644}, "location": {"width": 165, "top": 850, "height": 25, "left": 210}, "words": "±685ng小时/mL"}, {"probability": {"variance": 5.8e-05, "average": 0.996217, "min": 0.955616}, "location": {"width": 823, "top": 896, "height": 41, "left": 211}, "words": "中国健康患者空腹单次口服富马酸替诺福韦二吡呋酯300mg后,0.75小时达平均血清"}, {"probability": {"variance": 0.004317, "average": 0.962007, "min": 0.739848}, "location": {"width": 818, "top": 926, "height": 40, "left": 210}, "words": "峰浓度(Cmax)。Cmax和AUCr值分别为249ng/mL和2541 ng.hr/ml。中国健康受"}, {"probability": {"variance": 0.007915, "average": 0.976958, "min": 0.432559}, "location": {"width": 817, "top": 955, "height": 41, "left": 207}, "words": "试者空腹富马酸替诺福韦二吡呋酯300mg多次口服给药后,Cmax和AUC值分别为"}, {"probability": {"variance": 0.007999, "average": 0.972821, "min": 0.595198}, "location": {"width": 264, "top": 987, "height": 26, "left": 209}, "words": "328ng/mL和2460ngh/mL"}, {"probability": {"variance": 9e-06, "average": 0.998808, "min": 0.980319}, "location": {"width": 823, "top": 1035, "height": 37, "left": 209}, "words": "在富马酸替诺福韦二吡呋酯剂量为75~600mg之间时,替诺福韦的药代动力学和剂量"}, {"probability": {"variance": 2.9e-05, "average": 0.997243, "min": 0.979864}, "location": {"width": 328, "top": 1063, "height": 32, "left": 208}, "words": "呈比例关系,不受重复给药的影响"}, {"probability": {"variance": 0.000554, "average": 0.990799, "min": 0.852783}, "location": {"width": 811, "top": 1112, "height": 39, "left": 208}, "words": "食物对口服吸收的影响:在进食高脂肪餐(~700至1000kcal,含40%~50%的脂肪)"}, {"probability": {"variance": 0.000168, "average": 0.994993, "min": 0.922116}, "location": {"width": 789, "top": 1141, "height": 38, "left": 208}, "words": "后,口服富马酸替诺福韦二吡呋酯300mg,口服生物利用度增加,替诺福韦AUC"}, {"probability": {"variance": 0.001208, "average": 0.987796, "min": 0.786771}, "location": {"width": 855, "top": 1169, "height": 40, "left": 208}, "words": "增加约40%,Cmax增加约14%。然而富马酸替诺福韦二吡呋酯和清淡食物一起给药时;"}, {"probability": {"variance": 0.000113, "average": 0.996199, "min": 0.938271}, "location": {"width": 793, "top": 1197, "height": 38, "left": 208}, "words": "与空腹给药相比,对替诺福韦的药代动力学没有显著影响。食物使替诺福韦到达C"}, {"probability": {"variance": 0.001468, "average": 0.988759, "min": 0.767437}, "location": {"width": 812, "top": 1226, "height": 39, "left": 207}, "words": "的时间延迟了大约1小时。在进食状态下,不控制食物的成分,富马酸替诺福韦二吡"}, {"probability": {"variance": 0.004092, "average": 0.978894, "min": 0.595612}, "location": {"width": 812, "top": 1254, "height": 40, "left": 207}, "words": "呋酯300mg每天一次,多次给药后替诺福韦的Cma和AUC分别是0.33±0.12μg/mI"}, {"probability": {"variance": 0.000887, "average": 0.979757, "min": 0.880532}, "location": {"width": 215, "top": 1285, "height": 28, "left": 208}, "words": "和3.32±1.37μghr/mL"}], "language": 3}